Select a State

Global health R&D delivers for Hawaii

US government investment in global health R&D has delivered

$8.0 million
to Hawaii research institutions
100+ new jobs
for Hawaii

Neglected diseases in Hawaii

Chikungunya cases
34
Dengue cases
231
HIV diagnoses
852
Malaria cases
30
Tuberculosis cases
1,093
West Nile cases
1
Zika cases
17

Hawaii's top USG-funded global health R&D institutions

University of Hawaii at Manoa
$7.6 million
University of Hawaii at Hilo
$429 thousand

Hawaii industry in global health R&D

Hawaii Biotech
Location(s):
Honolulu

Hawaii's top areas of global health R&D by USG funding

48.9%
Malaria
5.4%
Tuberculosis
6.3%
Ebola/viral hemorrhagic fevers
38.5%
Neglected tropical diseases
Dengue
0.9%
Other
Non-allocable

Global health R&D at work in Hawaii

Researchers at the University of Hawaii are studying the Zika virus to unlock new approaches and treatments to prevent the virus from being transmitted from pregnant mother to fetus. They want to understand how Zika is transmitted to the fetus and how infection can impair infants, causing developmental delays and physical disorders. They are also examining whether the timing of infection during pregnancy affects the damage it causes. Hawaii is particularly at risk for transmission of Zika due to its favorable climate and numerous visitors from all over the world, including from countries where Zika is widespread. Several cases of Zika have been reported in the state. Supported by the National Institutes of Health, the Zika virus research is important to the health and economy of Hawaii.

Footnotes